PharmAbcine Inc
KOSDAQ:208340
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PharmAbcine Inc
KOSDAQ:208340
|
KR |
|
A
|
Adamant Holding Inc
F:U060
|
CA |
|
B
|
BayCom Corp
F:B2J
|
US |
|
Arterra Bioscience SpA
MIL:ARBS
|
IT |
|
E
|
EBest Investment & Securities Co Ltd
KOSDAQ:078020
|
KR |
|
V
|
Value-Holdings International AG
XBER:NW4
|
DE |
|
T
|
Talenthouse AG
XMUN:N7V
|
CH |
|
Ko Gold Inc
OTC:KOGDF
|
CA |
|
Lottomatica Group SpA
F:I56
|
IT |
|
Medirom Healthcare Technologies Inc
NASDAQ:MRM
|
JP |
|
R
|
Russel Metals Inc
F:RMZ
|
CA |
|
Kootenay Silver Inc
F:3FX
|
CA |
|
Virtu Financial Inc
LSE:0A7X
|
US |
|
T
|
Tiscon AG
DUS:TIS
|
DE |
|
B
|
Beazley PLC
OTC:BZLYF
|
UK |
|
RC Fornax PLC
F:8AD
|
UK |
|
R
|
RC365 Holding PLC
LSE:RCGH
|
UK |
|
P
|
PFL Infotech Ltd
BSE:531769
|
IN |
|
M
|
Mercado Minerals Ltd
OTC:MRMNF
|
CA |
|
C
|
Centogene NV
F:39K
|
DE |
|
Y
|
Yokogawa Electric Corp
DUS:YKE
|
JP |
|
J
|
Jungheinrich AG
XHAN:JUN3
|
DE |
|
Serstech AB
F:284
|
SE |
|
Indigo Exploration Inc
OTC:IXIXD
|
CA |
Bankruptcy Probability
PharmAbcine Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PharmAbcine Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
P
|
PharmAbcine Inc
KOSDAQ:208340
|
9.2B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
468.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
181.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PharmAbcine Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PharmAbcine Inc has total debt of 700.2m KRW. This includes both short-term (0 KRW) and long-term (700.2m KRW) debt.
You can find a full breakdown on its Balance Sheet.
